25fdc054-c845-471d-bea7-10d0f1f3bdc7 (1).pdf
The impact on IIFL Finance is very minimal nearly negligible…it’s a great opportunity to buy at 590…!!
25fdc054-c845-471d-bea7-10d0f1f3bdc7 (1).pdf
The impact on IIFL Finance is very minimal nearly negligible…it’s a great opportunity to buy at 590…!!
Major scuttlebutt completed.
Don’t be surprised if you see Skipper Ltd at 2x of CMP within 12 months.*
*T&C apply, always.
Sure. Let’s plan a meet-up soon. If anyone is interested please DM me or post here and I’ll add you to the group here
Dev LabTech-84
Market cap-69 cr
What does company do?
Dev Labtech Venture Ltd. (DLVL) is in the business of manufacturing, marketing and sourcing diamonds – Natural and Lab-grown having wide application in Jewellery.
Dev Labtech Venture Ltd
ABOUT
Incorporated in 1993, Dev Labtech Venture Limited is a Premier Lab Grown Diamond & Jewellery Manufacturer.
KEY POINTS
Business Area- Dev Labtech Venture Ltd. (DLVL) is in the business of manufacturing, marketing and sourcing diamonds – Natural and Lab-grown having wide application in Jewellery.
Revenue Bifurcation – Product wise-
Lab Grown Diamonds – 39% in 6M ended FY23 vs Nil in FY22
Natural Diamonds – 61% in 6M ended FY23 vs 100% in FY22
A) Lab-Grown Diamonds-Company has recently started manufacturing lab-grown diamonds. Earlier, it was engaged in only processing of natural diamonds.
Manufacturing Process- Co. used Microwave Plasma Chemical Vapour Disposition (MPCVD) method to make lab-grown Diamonds from Diamond Seed. MPCVD is a pure and fast diamond deposition process, hence best suited for commercial uses.
Application for Lab-grown Diamonds-Apart from being used as Jewellery, Lab-grown diamonds are used for Machining and cutting tools, Thermal conductors, Optical materials, Electronics, Semi-Conductors Electronic Industries etc.
B) Natural Diamonds-Co. process diamonds of multiple shapes, cuts, sizes, colours and clarity which are utilised for Jewellery, Ornaments and other Industrial cutting tools.
Customers:- DLVL has developed regular clients for supply of diamonds in Bhavnagar, Surat, and Mumbai, and for exports. Its products are primarily targeted to customers engaged in natural and lab-grown diamond jewellery manufacturers.
Revenue Bifurcation – Product wise-
Lab Grown Diamonds – 39% in 6M ended FY23 vs Nil in FY22
Natural Diamonds – 61% in 6M ended FY23 vs 100% in FY22
72% in India and 28% export
Promoter holding near 68%
source screener
Trigger for me-
Preferential issue promoters and investors are investing near 22 cr at 64 rs a share…lab grown diamond have huge potential.
Disc- currently tracking
Jtl Industries -237
Last 5 year profit growth is over 60%
Sector- Structural steel tubes
Trigger -Recent announcement of preferential issue in which promoters will be investing Rs 500 cr at Rs 270/, which itself is atleast 10% argitrage…
Company recently announced Rs 1300 cr of expansion in structural steel tubes in which apl Apollo is Market leader and now jtl is getting very aggressive and valuations wise is cheaper than apl Apollo. Promoters have huge skin in the game and with this mega expansion it opens new growth paths and recently in an interview Amit jeswani of stallion asset bought shares near 196 he’ s superb investor and promoter also bought from open market at 201…volumes are huge nowadays…compare to Apl Apollo they are so small and they are the best candidate who can give a great fight…so that’s a huge opportunity.
Investor and biased
Praveg-658
Market cap-1490 cr
Triggers;-
On 26th December there’s a board meeting for issue of raising money…most probably preferential issue… company is continuously getting more orders… company is on hyper growth path…q3 is usually the strongest… companies lot of new properties are becoming operational…valutions looking at future growth and management track record looks cheap…sage one owns near 1.75%, they are one of the smartest investors in Bharat.
The markets have gone mental, High PE and low growth stocks are making new highs every day with anticipation of growth and news while good companies with sound financials and decent valuations are dead.
40% of DCX Systems revenue comes from Israel. With the ongoing war, there could be delay in receivables from Israel side, and affect the upcoming quarterly earnings. Any inputs on that?
Red flags like promoter reducing stake + MD resigning are there.
Still tracking because, it is trying to move up the value chain and offering customised services, pivot from a generic testing company. (Like a CRAMS player expanding/specialising their portfolio, spending more on R&D)
Will look for margin expansion to happen.
If any other views pls share.
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!